Relevant bibliographies by topics / Central Nervous System Stimulant

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Central Nervous System Stimulant'

Author: Grafiati
Published: 3 June 2025
Last updated: 1 August 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Central Nervous System Stimulant.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Central Nervous System Stimulant"

1

Sireesha, Kalva* Ramya Yenni Arravolu Madhu. "A Comparative Evaluation Of Central Nervous System Acting Drugs By Screening Models." International Journal in Pharmaceutical Sciences 1, no. 10 (2023): 165–69. https://doi.org/10.5281/zenodo.10017308.

Full text
Abstract:
Drugs that stimulate or depress CNS play an important role in human therapeutics. Undesirable side effects and ineffectiveness of currently available CNS stimulants or depressants in many situations call for development of novel drugs. This study  was designed for screening the activity of drugs for central nervous system. More particularly to compare the efficay of marketed CNS drugs with herbal drugs. CNS stimulant drugs Unicontin, Armodafinil, Bacopa monnieri were choosen and their locomotor activity was screened using Actophotometer. Bacopa monnieri was found to be equally potent to A
APA, Harvard, Vancouver, ISO, and other styles
2

GUPTA, MOHIT, RAVI SHEKHAR, and JAGDISH K. SAHU. "ROLE OF DRUG DISCOVERY IN CENTRAL NERVOUS SYSTEM DISORDERS: AN OVERVIEW." Current Research in Pharmaceutical Sciences 11, no. 3 (2021): 86–90. http://dx.doi.org/10.24092/crps.2021.110302.

Full text
Abstract:
Central nervous system (CNS) stimulants are drugs, which produce a response that could be used to alleviate a particular medical condition. These are the agents, which speed up to treat conditions characterized by lack of adrenergic stimulation, including narcolepsy and neonatal apnea. The majority of CNS stimulants is chemically similar to the neurohormone norepinephrine and simulates the traditional "fight or flight" syndrome associated with sympathetic nervous system arousal. A small figure of added members of the CNS stimulant class do not fall into definite chemical groups. The review on
APA, Harvard, Vancouver, ISO, and other styles
3

Levy, Florence. "CNS Stimulant Controversies." Australian & New Zealand Journal of Psychiatry 23, no. 4 (1989): 497–502. http://dx.doi.org/10.3109/00048678909062617.

Full text
Abstract:
Controversies in the use of central nervous system stimulant medications in children with attention deficit hyperactivity disorder are discussed. Diagnostic issues, age of optimal use, side effects, effects on learning and ethical considerations are current issues. An animal model for the effects of chronic long-term high dose regimes is proposed.
APA, Harvard, Vancouver, ISO, and other styles
4

George, Alan J. "Central nervous system stimulants." Best Practice & Research Clinical Endocrinology & Metabolism 14, no. 1 (2000): 79–88. http://dx.doi.org/10.1053/beem.2000.0055.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sk., Irfan Khan* B. Navya Chandan kumar Dr.Y.Krishna Reddy DR.K.N.V.Rao Dr. K. Rajeswar dutt. "FORMULATION, OPTIMIZATION AND EVALUATION OF CAFFEINE EFFERVESCENT TABLETS." INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES 05, no. 04 (2018): 2222–29. https://doi.org/10.5281/zenodo.1215140.

Full text
Abstract:
The present study aims at developing a caffeine effervescent tablet formulation for the effective treatment of the central nervous system as it acts central nervous system stimulant of the methylxanthine class. And this dosage form is to provide the patient with the most convenient mode of administration, effervescent tablets will dissolve quickly in water and it releases CO2. And effervescent tablet contains caffeine acts as central nervous system stimulant within seconds of time it will simulate the CNS, onset of action is rapid. Caffeine is a central nervous system stimulant of methyl xanth
APA, Harvard, Vancouver, ISO, and other styles
6

Moore, Thomas J., Phillip W. Wirtz, Jill N. Curran, and G. Caleb Alexander. "Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis." BMJ Open 13, no. 4 (2023): e069668. http://dx.doi.org/10.1136/bmjopen-2022-069668.

Full text
Abstract:
ObjectiveExamine patterns of adult medical use of amphetamine and methylphenidate stimulant drugs, classified in the USA as Schedule II controlled substances with a high potential for psychological or physical dependence.DesignCross-sectional study.Setting and participantsPrescription drug claims for US adults, age 19–64 years, included in a commercial insurance claims database with 9.1 million continuously enrolled adults from 1 October 2019, through 31 December 2020. Stimulant use was defined as adults filling one or more stimulant prescriptions during calendar 2020.Outcome measuresThe prima
APA, Harvard, Vancouver, ISO, and other styles
7

Ikeda-Murakami, Kei, Naoto Tani, Tomoya Ikeda, Yayoi Aoki, and Takaki Ishikawa. "Central Nervous System Stimulants Limit Caffeine Transport at the Blood–Cerebrospinal Fluid Barrier." International Journal of Molecular Sciences 23, no. 3 (2022): 1862. http://dx.doi.org/10.3390/ijms23031862.

Full text
Abstract:
Caffeine, a common ingredient in energy drinks, crosses the blood–brain barrier easily, but the kinetics of caffeine across the blood–cerebrospinal fluid barrier (BCSFB) has not been investigated. Therefore, 127 autopsy cases (Group A, 30 patients, stimulant-detected group; and Group B, 97 patients, no stimulant detected group) were examined. In addition, a BCSFB model was constructed using human vascular endothelial cells and human choroid plexus epithelial cells separated by a filter, and the kinetics of caffeine in the BCSFB and the effects of 4-aminopyridine (4-AP), a neuroexcitatory agent
APA, Harvard, Vancouver, ISO, and other styles
8

ANGRIST, BURT, MARILYN D??HOLLOSY, MICHAEL SANFILIPO, et al. "Central Nervous System Stimulants as." Journal of Clinical Psychopharmacology 12, no. 4 (1992): 268???272. http://dx.doi.org/10.1097/00004714-199208000-00009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Evenden, J. L., and C. N. Ryan. "Behavioral responses to psychomotor stimulant drugs: Localization in the central nervous system." Pharmacology & Therapeutics 36, no. 2-3 (1988): 151–72. http://dx.doi.org/10.1016/0163-7258(88)90104-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Moore, Thomas J., Phillip W. Wirtz, Stefan P. Kruszewski, and G. Caleb Alexander. "Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study." BMJ Open 11, no. 8 (2021): e048528. http://dx.doi.org/10.1136/bmjopen-2020-048528.

Full text
Abstract:
ObjectiveTo assess the 5-year changes in the adult medical use of central nervous system (CNS) stimulants with higher risk of dependence and evaluate the population characteristics of users and their medical and/or neurological conditions.DesignCross-sectional study.SettingAnnual US Medical Expenditure Panel Survey, a stratified random sample of approximately 30 000 persons designed to produce national population estimates. It focuses on reported medical spending, medical services used, health status and prescription medications.ParticipantsAdults age 19 years and older who reported obtaining
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Central Nervous System Stimulant"

1

Slattum, Patricia W. "EVALUATION OF QUANTITATIVE ELECTROENCEPHALOGRAPHY FOR ASSESSMENT OF CENTRAL NERVOUS SYSTEM STIMULANT RESPONSE." VCU Scholars Compass, 1992. https://scholarscompass.vcu.edu/etd/5524.

Full text
Abstract:
The objective of this investigation was to evaluate quantitative electroencephalography (EEG) as a measure of CNS stimulation. The reproducibility and sensitivity of quantitative EEG was compared to neuroendocrine, mood, and psychomotor performance measures. The study was conducted in two parts. The first part investigated the inter- and intra-individual variability associated with a series of pharmacological response measures under baseline (no drug) conditions. It was an open-label pilot study in which eight healthy male volunteers underwent a series of tests (EEG, visual continuous performan
APA, Harvard, Vancouver, ISO, and other styles
2

CONTU, LILIANA. "Influence of Amphetamine-type stimulants in the Central Nervous System: abuse and neurotoxicity." Doctoral thesis, Università degli Studi di Cagliari, 2018. http://hdl.handle.net/11584/255975.

Full text
Abstract:
Amphetamines are synthetic drugs characterized by their psychostimulants effects on the central nervous system (CNS), and include a wide range of substances such as alpha-methylphenethylamine or amphetamine (AMPH), N-methylamphetamine or methamphetamine (METH) and 3,4 methylenedioxymethamphetamine (MDMA) also known as “ecstasy”. The ATS, structurally, are a group of substances related to the compound known as β-phenethylamine (β-PEA), a naturally neurotransmitter in the body. Structural modifications on the aromatic ring of β-PEA create multiple synthetic derivatives with different pharmacolo
APA, Harvard, Vancouver, ISO, and other styles
3

Schroeder, Frederick Albert. "A Role for Histone Modification in the Mechanism of Action of Antidepressant and Stimulant Drugs: a Dissertation." eScholarship@UMMS, 2007. https://escholarship.umassmed.edu/gsbs_diss/370.

Full text
Abstract:
Depression and stimulant drug addiction each result in massive losses of health, productivity and human lives every year. Despite decades of research, current treatment regimes for depression are ineffective in approximately half of all patients. Therapy available to stimulant drug addicts is largely ineffective and moreover, dedicated treatments for drug dependence (including abuse of cocaine) are non-existent. Thus, there is a pressing need to further understanding of the molecular mechanisms underlying these disorders in order to develop novel, targeted therapeutic strategies. Chromatin rem
APA, Harvard, Vancouver, ISO, and other styles
4

Beaumont, Ross. "The performance and physiological effects of caffeine and octopamine supplementation during endurance cycle exercise." Thesis, Loughborough University, 2017. https://dspace.lboro.ac.uk/2134/25522.

Full text
Abstract:
Caffeine consistently enhances endurance performance in temperate environmental conditions, while far less research has examined its ergogenic and physiological effects during prolonged exercise in the heat. Despite the performance benefit of an acute caffeine doses being less pronounced in regular caffeine users versus those not habituated to the drug, few studies have examined the influence of a prolonged period of controlled caffeine intake on endurance performance. The endogenous trace amine octopamine is purported to possess stimulant-like properties and influence fat metabolism, although
APA, Harvard, Vancouver, ISO, and other styles
5

Hedström, Kajsa, and Ulrika Hillbom. "Tillväxt hos barn och ungdomar som behandlats med centralstimulatia : En journalgranskningsstudie." Thesis, Uppsala universitet, Institutionen för folkhälso- och vårdvetenskap, 2011. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-154710.

Full text
Abstract:
Syfte: Att undersöka om det fanns något samband mellan behandling med centralstimulantia ochavvikande tillväxt hos barn och ungdomar med ADHD, samt att undersöka om eventuellt avvikandetillväxt hade något samband med ålder vid insättande, kön eller olika funktionshinder.Metod: 68 barn med ADHD som behandlats med centralstimulantia i minst två år inkluderades.Journalkopior inhämtades från Habiliteringen för barn och vuxna vid Uppsala läns landsting. Dessakopior innehöll barnens tillväxtkurvor, kön, diagnos och ålder. Kurvorna granskades med hjälp av enutformad granskningsmall. Barnens tillväxt
APA, Harvard, Vancouver, ISO, and other styles
6

Fagergren, Pernilla. "Cocaine effects on striatal dynorphin and CART neuropeptides : association to mood disorder /." Stockholm, 2003. http://diss.kib.ki.se/2003/91-7349-515-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gauffin, Per. "Underlättar medicinering av barn med ADHD barnets pedagogiska situation i skolan?" Thesis, Karlstad University, Faculty of Arts and Education, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:kau:diva-1514.

Full text
Abstract:
<p>Persons suffering from Attention deficit/hyperactivity disorder (ADHD) struggle with complications within the functions that regulate and control the brain activities, due to deficiencies in these functions within the affected nerve-paths. ADHD is a cognitive function impairment characterised by inattention, impulsiveness and over activity. According to Diagnostic and Statistic Manual of Mental Disorders, American Psychiatric Association (DSM-IV), certain diagnostic criteria of ADHD must be fulfilled in order for a person to be diagnosed with ADHD. The everyday problems caused by ADHD are i
APA, Harvard, Vancouver, ISO, and other styles
8

Strandberg, Joakim. "Toxicological studies of opiate-related death /." Stockholm, 2007. http://diss.kib.ki.se/2007/978-91-7357-191-3/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Junior, Hercilio Pereira de Oliveira. "Alterações neurocognitivas e morfométricas cerebrais associadas ao uso do crack." Universidade de São Paulo, 2018. http://www.teses.usp.br/teses/disponiveis/5/5142/tde-12092018-082935/.

Full text
Abstract:
INTRODUÇAO: Recentes achados experimentais sugerem que a cocaína na forma crack é mais neurotóxica quando comparada à cocaína inalada. Estes estudos são congruentes com os achados clínicos de que pacientes com transtorno por uso da cocaína e usuários de crack têm pior prognóstico e mais consequências adversas para à saúde. OBJETIVO: Investigar alterações diferenciais em substância cinzenta cerebral (SC) e prejuízos neurocognitivos entre usuários de crack (CRACK), cocaína inalada (COC) e controles. MÉTODOS: 78 indivíduos adultos foram avaliados neste estudo (16 CRACK, 26 COC e 36 controles). To
APA, Harvard, Vancouver, ISO, and other styles
10

Martinsson, Louise. "Facilitation of recovery after ischaemic stroke : early dexamphetamine and physiotherapy treatment /." Stockholm, 2003. http://diss.kib.ki.se/2003/91-7349-668-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Central Nervous System Stimulant"

1

Miller, Richard Lawrence. The encyclopedia of addictive drugs. Greenwood Press, 2002.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Engs, Ruth C. Alcohol and other drugs: Self-responsibility. Tichenor Pub., 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Larsen, Robert E. Medical aspects of chemical dependency handbook: For nonmedical professionals. Hazelden, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

service), ScienceDirect (Online, ed. Neuromodulation. Elsevier, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Sahley, Billie Jay. GABA: The anxiety amino acid. Pain & Stress Center, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Sahley, Billie Jay. GABA: The anxiety amino acid. 3rd ed. Pain & Stress Publications, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sharma, Hari Shanker. New concepts of psychostimulant induced neurotoxicity. Elsevier, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Emerich, Dwaine F., Reginald L. Dean, and Paul R. Sanberg, eds. Central Nervous System Diseases. Humana Press, 2000. http://dx.doi.org/10.1007/978-1-59259-691-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Ahluwalia, Manmeet, Philippe Metellus, and Riccardo Soffietti, eds. Central Nervous System Metastases. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-23417-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ramakrishna, Rohan, Rajiv S. Magge, Ali A. Baaj, and Jonathan P. S. Knisely, eds. Central Nervous System Metastases. Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-42958-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Central Nervous System Stimulant"

1

Hsu, Eric S. "Central Nervous System Stimulants." In Essentials of Pharmacology for Anesthesia, Pain Medicine, and Critical Care. Springer New York, 2014. http://dx.doi.org/10.1007/978-1-4614-8948-1_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Buelke-Sam, Judy. "Postnatal Functional Assessment following Central Nervous System Stimulant Exposure." In Handbook of Behavioral Teratology. Springer US, 1986. http://dx.doi.org/10.1007/978-1-4613-2189-7_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Nielsen, E. B., and J. Scheel-Krüger. "Central Nervous System Stimulants: Neuropharmacological Mechanisms." In Transduction Mechanisms of Drug Stimuli. Springer Berlin Heidelberg, 1988. http://dx.doi.org/10.1007/978-3-642-73223-2_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Brown, Ritchie E. "Dopaminergic Transmission and Wake-Promoting Effects of Central Nervous System Stimulants." In Dopamine and Sleep. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-46437-4_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Elgazzar, Abdelhamid H., and Ismet Sarikaya. "Central Nervous System." In Nuclear Medicine Companion. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-76156-5_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mino, Miriame, Krisztian Homicsko, and Roger Stupp. "Central Nervous System." In Side Effects of Medical Cancer Therapy. Springer London, 2012. http://dx.doi.org/10.1007/978-0-85729-787-7_7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Elgazzar, Abdelhamid H. "Central Nervous System." In Synopsis of Pathophysiology in Nuclear Medicine. Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-03458-4_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Klingensmith, William C. "Central Nervous System." In The Mathematics and Biology of the Biodistribution of Radiopharmaceuticals - A Clinical Perspective. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-26704-3_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Yu, Yao, Steve E. Braunstein, Daphne A. Haas-Kogan, and Jean L. Nakamura. "Central Nervous System." In Handbook of Evidence-Based Radiation Oncology. Springer International Publishing, 2018. http://dx.doi.org/10.1007/978-3-319-62642-0_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Timperley, W. R., J. M. MacKenzie, and S. F. D. Robinson. "Central nervous system." In Reporting Histopathology Sections. Springer US, 1997. http://dx.doi.org/10.1007/978-1-4899-7132-6_23.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Central Nervous System Stimulant"

1

Lebedeva, N. N. "Asymmetry of Reactions of Human Central Nervous System to Electromagnetic Fields." In EMC_1990_Wroclaw. IEEE, 1990. https://doi.org/10.23919/emc.1990.10833035.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

"PV-087 - PERSONALITY DISORDER AND MODAFINIL DEPENDENCE – A CASE REPORT." In 24 CONGRESO DE LA SOCIEDAD ESPAÑOLA DE PATOLOGÍA DUAL. SEPD, 2022. http://dx.doi.org/10.17579/abstractbooksepd2022.pv087.

Full text
Abstract:
Introduction: Comorbidity of personality and substance use disorders, including prescription drug abuse, is common in clinical practice. We present a case report of a patient with a diagnosis of a personality disorder and symptoms of modafinil dependence. Case report: 33-year-old male, single, unemployed for over 3 years. He started psychological treatment at the age of 17 due to anxiety symptoms. Since the age of 21 he had irregular consultations with several psychiatrists in private practice. He received several diagnoses, including anxiety, depression, obsessive compulsive disorder and pers
APA, Harvard, Vancouver, ISO, and other styles
3

Moreira, Lorrane de Moura, Bruna Stefany Alves Françozo, Bruno Barcelos Pereira, et al. "Diagnosis and treatment of Multiple sclerosis: Brazilian and global overview." In XIII Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2021. http://dx.doi.org/10.5327/1516-3180.490.

Full text
Abstract:
Introduction: Multiple sclerosis (MS) is a neurodegenerative autoimmune disease of the central nervous system with a chronic, progressive and inflammatory character. In addition, it presents itself in a heterogeneous way, and can be as an isolated syndrome or as a recurrent remitter, in the first stage, or as progressive, in the second stage. The present work was developed with the objective of determining which is the best form of diagnosis and therapy for multiple sclerosis in Brazil. Methods: The review was performed in PubMed platform, with the descriptors: “multiple sclerosis”, “diagnosis
APA, Harvard, Vancouver, ISO, and other styles
4

Malyutina, T. A. "NEUROPEPTIDES INVOLVING IN THE REGULATION OF LOCOMOTOR BEHAVIOR OF ROOT-KNOT PLANT-PARASITIC NEMATODES (REVIEW)." In THEORY AND PRACTICE OF PARASITIC DISEASE CONTROL. All-Russian Scientific Research Institute for Fundamental and Applied Parasitology of Animals and Plant – a branch of the Federal State Budget Scientific Institution “Federal Scientific Centre VIEV”, 2023. http://dx.doi.org/10.31016/978-5-6048555-6-0.2023.24.281-284.

Full text
Abstract:
In the last few decades, the attention of researchers has been attracted by endogenous&#x0D; FMRFamide-like neuropeptides found in a number of invertebrates, including&#x0D; species of the Nematoda phylum. A foreign literature review was presented for&#x0D; the functional significance of endogenous FMRFamide-like neuropeptides in&#x0D; locomotor behaviour of root-knot phytonematodes, representatives of the genus&#x0D; Meloidogyne Goldi, 1982, namely, Meloidogyne incognita, M. minor, M. hapla and&#x0D; M. graminicola. In Russia, such studies are not carried out. The main characteristics&#x0D; o
APA, Harvard, Vancouver, ISO, and other styles
5

Henoch-Schönlein Purpura, A., Gabriele Simonini, Eleonora Fusco, et al. "AB1015 CENTRAL NERVOUS SYSTEM VASCULITIS PRECEDING." In Annual European Congress of Rheumatology, EULAR 2019, Madrid, 12–15 June 2019. BMJ Publishing Group Ltd and European League Against Rheumatism, 2019. http://dx.doi.org/10.1136/annrheumdis-2019-eular.4663.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Vedala, Srivatsa, Ahsan Farooqi, and Brian De. "Central Nervous System Relapse of Sarcoma." In Radiation Oncology Medical Student Program. University of Texas MD Anderson Cancer Center, 2024. http://dx.doi.org/10.52519/00142.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Guck, Jochen R. "Optomechanical insights into the central nervous system." In Optical Elastography and Tissue Biomechanics VIII, edited by Kirill V. Larin and Giuliano Scarcelli. SPIE, 2021. http://dx.doi.org/10.1117/12.2578567.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Moreira, Laila Prazeres Schulz, Daniela Fernanda Almeida Santos, Guilherme Cordaro Bucker Furini, et al. "Central nervous system complications of pediatric sinusitis." In SBN Conference 2022. Thieme Revinter Publicações Ltda., 2023. http://dx.doi.org/10.1055/s-0043-1774460.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Correa, S., R. Nahar, B. D. Smighelschi, V. Vulkanov, and K. Guevarra. "Amidst Mimickers: Primary Central Nervous System Vasculitis." In American Thoracic Society 2024 International Conference, May 17-22, 2024 - San Diego, CA. American Thoracic Society, 2024. http://dx.doi.org/10.1164/ajrccm-conference.2024.209.1_meetingabstracts.a5613.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Barač, Anja, Ivona Jerković, and Petra Nimac Kozina. "Primary angiitis of the central nervous system (PACNS)." In NEURI 2015, 5th Student Congress of Neuroscience. Gyrus JournalStudent Society for Neuroscience, School of Medicine, University of Zagreb, 2015. http://dx.doi.org/10.17486/gyr.3.2223.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Central Nervous System Stimulant"

1

Ridgway, Sam H. The Cetacean Central Nervous System. Defense Technical Information Center, 1999. http://dx.doi.org/10.21236/ada381704.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Albquerque, Edson X. Molecular Targets for Organophosphates in the Central Nervous System. Defense Technical Information Center, 2004. http://dx.doi.org/10.21236/ada426356.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Rowland, Vernon, and Henry Gluck. Attention and Preparatory Processes in the Central Nervous System. Defense Technical Information Center, 1986. http://dx.doi.org/10.21236/ada171316.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Butler, F. K., and Jr. Central Nervous System Oxygen Toxicity in Closed-Circuit Scuba Divers. Defense Technical Information Center, 1986. http://dx.doi.org/10.21236/ada170879.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Clark, J. M., and C. J. Lambertsen. Extension of Central Nervous and Visual System Oxygen Tolerance in Physical Work. Defense Technical Information Center, 1990. http://dx.doi.org/10.21236/ada239160.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Mery, Laura, Matthew Wayner, John McQuade, and Erica Anderson. Characterization of the Effects of Fatigue on the Central Nervous System (CNS) and Drug Therapies. Defense Technical Information Center, 2007. http://dx.doi.org/10.21236/ada489794.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Catlin, Kristen M. Role of Cytokines and Neurotrophins in the Central Nervous System in Venezuelan Equine Encephalitis Pathogenesis. Defense Technical Information Center, 2001. http://dx.doi.org/10.21236/ad1012369.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zhong, Lin, Anqing Lu, Xiyue Lu, et al. Molecular mechanisms and therapeutic prospects of immunotherapy and targeted therapy in primary central nervous system lymphoma. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2024. https://doi.org/10.37766/inplasy2024.12.0103.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Li, Yanming, Zhigang Zhao, and Yuanbo Liu. Combined chemotherapy in new diagnosed primary central nervous system lymphoma: a systematic review and network meta‑analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2020. http://dx.doi.org/10.37766/inplasy2020.9.0084.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Carpenter, A. V., W. D. Flanders, E. L. Frome, D. J. Crawford-Brown, and S. A. Fry. Radiation exposure and central nervous system cancers: A case-control study among workers at two nuclear facilities. Office of Scientific and Technical Information (OSTI), 1987. http://dx.doi.org/10.2172/6646019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Central Nervous System Stimulant' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography